Big Payout Alert: Earn Rs 42 Dividend From Pharma Stock; How Dividend Hunters Can Trade Before Record Date?

With its headquarters located in India, GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) is a multinational healthcare organization that specializes in pharmaceuticals, vaccines, and general medicines. Following the company's reported topline growth and profitability for the full year ending March 31, 2025, coupled with a sizeable dividend, the pharmaceutical stock will be the focus of attention today.

GSK Pharma Dividend

"The Board has recommended a final dividend of Rs.42/- per equity share on face value of Rs.10 each for the year ended 31st March 2025, subject to approval of members at 100th Annual General Meeting," said the pharma giant in a stock exchange filing.

The company's 100th Annual General Meeting (AGM) has been scheduled for Friday, June 27, 2025 by the Board of Directors.

GSK Pharma Dividend Record Date

"The Company has fixed Friday, 30th May 2025, as the Record Date for determining entitlement of members to final dividend for the financial year ended 31st March,2025. If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on and after Monday, 30th June 2025," informed GSK Pharma stock exchanges.

GSK Pharma Q4 Results

GlaxoSmithkline Pharmaceuticals' consolidated net profit increased 35.17% to Rs 262.87 crore in the quarter that ended in March 2025 from Rs 194.48 crore in the quarter that ended in March 2024. Compared to the previous quarter, which ended in March 2024, when consolidated sales were Rs 929.80 crore, they increased by 4.79% to Rs 974.37 crore in the quarter that concluded in March 2025. EBITDA increased 30.23% from Rs. 287.09 crore in Q4FY24 to Rs. 373.87 crore in Q4FY25. In the year ending in March 2025, net profit increased 57.23% to Rs 927.58 crore, compared to Rs 589.96 crore in the year ending in March 2024. In FY25, sales increased by 8.56% to Rs 3749.21 crore, compared to Rs 3453.71 crore in FY24.

GSK Pharma Share Price Target

"GSK Pharma has bounced back from the ₹2,750 support zone and is currently facing resistance near ₹2,920. A successful close above ₹2,920 can lead to further upside toward ₹3,000-₹3,050. The structure is stabilizing with mild accumulation visible on the charts. Support remains intact at ₹2,800. Traders may consider entering above ₹2,900 for a momentum move, with a stop loss at ₹2,790," commented Riyank Arora - Technical Analyst - Mehta Equities Limited.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.